73 related articles for article (PubMed ID: 35350785)
1. HPK1 Dysregulation-Associated NK Cell Dysfunction and Defective Expansion Promotes Metastatic Melanoma Progression.
Choi WS; Kwon HJ; Yi E; Lee H; Kim JM; Park HJ; Choi EJ; Choi ME; Sung YH; Won CH; Sung CO; Kim HS
Adv Sci (Weinh); 2024 Jun; ():e2400920. PubMed ID: 38828677
[TBL] [Abstract][Full Text] [Related]
2. DOT1L maintains NK cell phenotype and function for optimal tumor control.
Sudholz H; Schuster IS; Foroutan M; Sng X; Andoniou CE; Doan A; Camilleri T; Shen Z; Zaph C; Degli-Esposti MA; Huntington ND; Scheer S
Cell Rep; 2024 Jun; 43(6):114333. PubMed ID: 38865244
[TBL] [Abstract][Full Text] [Related]
3. Healthcare Spending and Systemic Bevacizumab for Recurrent Respiratory Papillomatosis.
Schuman AD; Chapel AC; You P; Venkatramani R; Russell HV; Raol N; Ongkasuwan J
J Voice; 2024 Apr; ():. PubMed ID: 38664168
[TBL] [Abstract][Full Text] [Related]
4. Innatus immunis: Evolving paradigm of adaptive NK cells.
Khalil M; Malarkannan S
J Exp Med; 2022 Nov; 219(11):. PubMed ID: 36066493
[TBL] [Abstract][Full Text] [Related]
5. The role of HPV11 E7 in modulating STING-dependent interferon β response in recurrent respiratory papillomatosis.
Chen L; Hu H; Pan Y; Lu Y; Zhao M; Zhao Y; Wang L; Liu K; Yu Z
J Virol; 2024 May; 98(5):e0192523. PubMed ID: 38624230
[TBL] [Abstract][Full Text] [Related]
6. EMT-induced immune evasion: connecting the dots from mechanisms to therapy.
Imodoye SO; Adedokun KA
Clin Exp Med; 2023 Dec; 23(8):4265-4287. PubMed ID: 37966552
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanisms of Carcinogenesis in Pediatric Airways Tumors.
Soloperto D; Gazzini S; Cerullo R
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768522
[TBL] [Abstract][Full Text] [Related]
8. Overcoming the challenges in translational development of natural killer cell therapeutics: An opinion paper.
Qin H; You C; Yan F; Tan K; Xu C; Zhao R; Ekpo MD; Tan S
Front Oncol; 2022; 12():1062765. PubMed ID: 36531041
[No Abstract] [Full Text] [Related]
9.
Chen Z; Cui S; Dai Y; Lu C; Zhang H; Zhao W; Yan H; Zhang Y
Oxid Med Cell Longev; 2022; 2022():7595230. PubMed ID: 36193074
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived TGF-β1 mediates the down-modulation of NKG2D expression and may be responsible for impaired natural killer (NK) cytotoxicity in women with endometriosis.
Guo SW; Du Y; Liu X
Hum Reprod; 2016 Jul; 31(7):1462-74. PubMed ID: 27130956
[TBL] [Abstract][Full Text] [Related]
11. A review of the risk factors associated with juvenile-onset recurrent respiratory papillomatosis: genetic, immune and clinical aspects.
Li SL; Wang W; Zhao J; Zhang FZ; Zhang J; Ni X
World J Pediatr; 2022 Feb; 18(2):75-82. PubMed ID: 35072893
[TBL] [Abstract][Full Text] [Related]
12. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.
Moretta A; Bottino C; Vitale M; Pende D; Cantoni C; Mingari MC; Biassoni R; Moretta L
Annu Rev Immunol; 2001; 19():197-223. PubMed ID: 11244035
[TBL] [Abstract][Full Text] [Related]
13. Reduced NK Cell Cytotoxicity by Papillomatosis-Derived TGF-β Contributing to Low-Risk HPV Persistence in JORRP Patients.
Wu X; Xiao Y; Guo D; Zhang Z; Liu M
Front Immunol; 2022; 13():849493. PubMed ID: 35350785
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic Landscape of Gene Expression Profiles and Pathways in Juvenile-Onset Recurrent Respiratory Papillomatosis Tumor Tissues and Human Papillomavirus 6 and 11 E6- and E7-Overexpressing Head and Neck Squamous Cell Carcinoma Cell Lines.
Wu X; Xiao Y; Zhou S; Wang Y; Wang J
J Virol; 2022 Jan; 96(2):e0134221. PubMed ID: 34669519
[TBL] [Abstract][Full Text] [Related]
15. Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.
Wang W; Xi Y; Li S; Liu X; Wang G; Wang H; Pei M; Zhang J; Gui J; Ni X
J Virol; 2022 Oct; 96(19):e0094622. PubMed ID: 36154611
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
